Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
249.1 ILa | -3.86% | -6.35% | -16.91% |
Apr. 02 | Evogene Ltd. and The Kitchen FoodTech Hub Establishes Finally Foods Ltd | CI |
Mar. 20 | Evogene Receives Minimum Bid Price Non-Compliance Notice From Nasdaq | MT |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
Ratings chart - Surperformance
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.91% | 34.13M | - | - | |
+33.63% | 50.85B | B- | ||
-0.09% | 42.82B | B | ||
+49.62% | 42.03B | A | ||
-4.96% | 29.55B | C | ||
+11.18% | 26.11B | B- | ||
-21.95% | 19.13B | B | ||
+8.61% | 13.05B | B+ | ||
+28.31% | 12.16B | C+ | ||
+24.73% | 12.08B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EVGN Stock
- Ratings Evogene Ltd.